MPAM
KALA icon

Monarch Partners Asset Management’s KALA BIO KALA Stock Holding History

Monarch Partners Asset Management’s Portfolio KALA Stock Details KALA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-23
Closed -$434K – 196
2020
Q3 		$434K Buy
23
+11
+92% +$253K 0.1% 150
2020
Q2 		$309K Buy
12
+5
+71% +$142K 0.08% 167
2020
Q1 		$152K Buy
+7
New +$112K 0.05% 154

Other funds holding KALA

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CC
Caxton Corporation Princeton, New Jersey $4.02M AUM 256.08% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Monarch Partners Asset Management's KALA Position: Q4 2020 in Review

Monarch Partners Asset Management sold out of KALA BIO (KALA) in Q4 2020, closing a stake of 23 shares — an estimated $434K sold.

Monarch Partners Asset Management first reported a position in KALA in Q1 2020 and held it in 3 quarters. The position peaked at $434K in Q3 2020. 112 funds tracked by Wall St. Rank hold KALA as of Q4 2020.

  • Monarch Partners Asset Management reported no remaining KALA BIO position as of Q4 2020 after selling out during the quarter.
  • Monarch Partners Asset Management sold 23 KALA BIO shares in Q4 2020, an estimated $434K.
  • Monarch Partners Asset Management first reported a position in KALA BIO in Q1 2020 and held it in 3 quarters.
  • Monarch Partners Asset Management's KALA BIO position peaked at $434K in Q3 2020.
  • 112 funds tracked by Wall St. Rank held KALA BIO as of Q4 2020.

Based on Monarch Partners Asset Management's 13F filing for Q4 2020, filed 4 Feb 2021.